Peptide drug conjugates: How the Indena and Chemi partnership is delivering
The pharmaceutical industry is investing heavily in therapies capable of delivering high-potent treatments to diseased cells while limiting damage to…
The pharmaceutical industry is investing heavily in therapies capable of delivering high-potent treatments to diseased cells while limiting damage to…
Traditional approaches to patient-trial matching often rely solely on structured data, leading to inaccurate eligibility lists and missed opportunities to…
This is the first episode in our second season exploring the evolving landscape of real-world data and its role in…
As clinical trials become more digitalised, the data landscape is expanding faster than the processes designed to control it. Electronic…
Israel has a robust and growing clinical trials ecosystem. This podcast explores the factors that what make Israel such an…
Clinical trials are expensive, time-sensitive, and closely monitored, with sponsors and contract research organisations (CROs) under pressure to run studies…
Saudi Arabia is primed to emerge as the Middle East’s key hub for clinical trials, driven by both sustained state…
Clinical trial sites and sponsors are turning to eSource to ease pressures over costs and unlock efficiencies, with a recent…
As oncology pipelines continue to expand and targeted therapies become more sophisticated, contract development and manufacturing organisations (CDMOs) must invest…
Paradigm Health delivers a unified, AI-powered clinical research platform embedded within a national network of community and academic sites. By…